3D printing enables the creation of customized vaginal drug delivery systems that can improve women's healthcare by providing personalized, targeted, and controlled therapeutic solutions. Despite challenges, this innovative approach holds promise to unlock new possibilities for empowering women through advanced and patient-centric drug delivery technologies.

The chapter aligns well with several SDGs: it directly supports SDG 3 (Good Health and Well‑being) by focusing on female-specific health outcomes in space, and SDG 5 (Gender Equality) by addressing historic underrepresentation and research gaps. It also advances SDG 9 (Industry, Innovation and Infrastructure) via Artemis and AI-enabled research, and SDG 4 (Quality Education) and SDG 17 (Partnerships) through calls for expanded research capacity and collaboration. However, the chapter highlights a critical gap: insufficient female-specific data currently limits progress toward these goals and underscores the need for targeted investment and studies before AI and technological advances can fully deliver.

This paper supports SDG 3 and 13 by showing that the rise in night-time heat due to climate change, which is particularly strong in urban areas due to the urban heat island effect, could have implications for health. The study found a significant association between night-time excess heat and risk of hospitalisation. Rapid urbanisation in low-income and middle-income countries means the numbers of people exposed to excess night-time heat will increase.

This Article supports SDG 3 by evaluating the association between air pollutants and physical disability in older adults.

This chapter explores how rehabilitation and socially assistive robotics improve therapy for neurological conditions and older adults, addressing growing needs from aging populations and pandemic-driven isolation. By advancing innovative healthcare technologies and fostering collaboration, these solutions support SDG 3 (Good Health and Well-being) through better rehabilitation outcomes and SDG 9 (Industry, Innovation, and Infrastructure) by driving technological progress in clinical care.

Neurodegenerative disorders, such as Parkinson's disease (PD) and Alzheimer's disease (AD), have a global prevalence and profoundly impact both motor and cognitive functions.

In this review, Hu et al. summarize fluid biomarker findings across 12 anti-amyloid-β clinical trials. The emerging biomarker data provide evidence of impact of the new therapies on the underlying pathophysiological processes of the AD, supporting the presence of a disease-modifying effect.

This study demonstrates that the Psychological Telephone Triage System (PTT) is an effective and cost-efficient method for early identification of patients with urgent cognitive impairment, particularly in the context of Alzheimer’s disease (AD), helping to reduce unnecessary on-site visits and healthcare burden. The findings suggest that implementing this interdisciplinary pre-screening and triage process can improve management of the rising demand for dementia assessments, especially with new therapeutic options and increasing prevalence of dementia globally.